US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

234.59

-2.1300-0.90%

Volume:1K

Turnover:254.18K

Market Cap:470.71M

PE:- -

High:237.15

Open:237.15

Low:234.59

Close:236.72

52wk High:244.35

52wk Low:160.91

Shares:2.01M

Float Shares:2.01M

Volume Ratio:1.10

T/O Rate:0.05%

Dividend:0.95

Dividend Rate:0.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Gilead Sciences (GILD) Receives a Buy from Bernstein

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Amgen is Maintained at Equal-Weight by Wells Fargo

Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst

Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

Political and General News Events from September 3

Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target

Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan

NEJM publishes Phase 1/2 clinical data on daraxonrasib

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BBH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":234.59,"timestamp":1789744442418,"preClose":236.72,"halted":0,"volume":1077,"delay":0,"changeRate":-0.008997972287935094,"floatShares":2006503,"shares":2006503,"eps":0,"marketStatus":"Trading","change":-2.13,"latestTime":"09-18 11:19:53 EDT","open":237.145,"high":237.145,"low":234.59,"amount":254182.48997999998,"amplitude":0.010793,"askPrice":234.71,"askSize":200,"bidPrice":234.46,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789761600000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":236.72,"sharesOutstanding":1976503,"nav":231.19491,"aum":487012772.66,"dividendRate":0.00404,"bidAskSpread":0.001112,"preHourTrading":{"tag":"盘前","latestPrice":236.72,"preClose":236.72,"latestTime":"04:00 EDT","volume":1,"amount":236.72,"timestamp":1789718407582,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":236.72,"preClose":236.72,"latestTime":"19:30 EDT","volume":21,"amount":4970.46,"timestamp":1789687802811,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.098899,"impliedVol":0.1885,"impliedVolPercentile":0.3865},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":2006503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.098899,"shares":2006503,"dividePrice":0.9478,"high":237.145,"amplitude":0.010793,"preClose":236.72,"low":234.59,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":234.59,"committee":-0.333333,"eps":0,"divideRate":0.00404,"volume":1077,"delay":0,"ttmEps":0,"open":237.145,"prevYearClose":189.2649,"prevWeekClose":229.3922,"prevMonthClose":236.396,"prevQuarterClose":203.2373,"fiveDayClose":229.3922,"twentyDayClose":237.1125,"sixtyDayClose":194.9611},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665532340","title":"Why the Dow is Being Dragged Down by a Swiss Company's Bad News","url":"https://stock-news.laohu8.com/highlight/detail?id=2665532340","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665532340?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:15","pubTimestamp":1788855300,"startTime":"0","endTime":"0","summary":"Bad news from Swiss pharmaceutical giant Novartis was weighing on the Dow on Tuesday.Investors returning from the Labor Day break could be forgiven for wondering if their eyes were deceiving them, but","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","BK4533","NVS","BK4532","NAMS","BK4581","IE00B2B36J28.USD","LU1983299246.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","IE0002141913.USD","LU2112291526.USD","LU0070302665.USD","AMGN","LU1057294990.SGD","IBBQ","LU2242652126.USD","LU0109394709.USD","LU0889565916.HKD","LU1571399168.USD","LU0320765489.SGD","BK4139","LU0211331839.USD","SG9999001440.SGD","IBB","TBXU","LU0058720904.USD","LU0320765992.SGD","BK4566","PPH","BBH","IE00BJJMRZ35.SGD","BK4578","BK4588","LU0208291251.USD","MEDX","BK4599","PBE","BK4007","LU1061106388.HKD","PJP","BK4534","BIB","BK4585","LU2089984988.USD","LU0868494617.USD","LU0289739699.SGD","LU0122379950.USD","LU2468319806.SGD","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665317041","title":"Gilead Sciences (GILD) Receives a Buy from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2665317041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665317041?lang=en_us&edition=fundamental","pubTime":"2026-09-08 00:25","pubTimestamp":1788798346,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Buy rating on Gilead Sciences today and set a price target of $160.00. Breen covers the Healthcare se...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/gilead-sciences-gild-receives-a-buy-from-bernstein-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","TMED","BK4566","LU2468319806.SGD","SG9999015945.SGD","BK4581","GILD","LU0114720955.EUR","LU0234570918.USD","LU1674673428.USD","TBXU","BK4139","IE00B19Z3B42.SGD","LU0965508806.USD","LU1934455277.USD","IE00B7SZLL34.SGD","LU1934455194.USD","LU1585245621.USD","BK4578","SG9999015952.SGD","BK4585","IBBQ","LU0823416689.USD","LU1778281490.HKD","MEDI","XBI","IBB","IE00BZ1G4Q59.USD","LU2112291526.USD","LU2324357040.USD","BK4550","SG9999015978.USD","IE00B3T34201.USD","XLV","LU2089984988.USD","LABU","IE0002270589.USD","LU1037948541.HKD","BBH","IE00BSNM7G36.USD","LU0882574055.USD","LU1571399168.USD","BK4588","IE00BKVL7J92.USD","LU1934455863.HKD","LU0122379950.USD","LU1839511570.USD","BIB","BMED","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665739003","title":"Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665739003","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665739003?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.2% to 5.47 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Sino Biopharmaceutical Ltd. closed 40% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. fell 0.1% and Amgen Inc. remained unchanged.Trading volume totaled 42.8 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU2242652126.USD","BK1589","HK0000165453.HKD","AMGN","LU2468319806.SGD","BK1521","SG9999001440.SGD","LU1057294990.SGD","LU2089984988.USD","BK4566","LU0889565916.HKD","PJP","IBB","BBH","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1023059063.AUD","IBBQ","LU1061106388.HKD","IE00BZ08YR35.GBP","LU0058720904.USD","LU2242646821.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","IE00BZ08YS42.EUR","PBE","IE00BJT1NW94.SGD","IE00BZ08YT58.USD","LU0109394709.USD","LU2112291526.USD","BK4139","TBXU","BK4588","IE0009355771.USD","BK4599","BIB","BK4533","BK1191","BK4581","LU1571399168.USD","BK4534","BK1515","LU0122379950.USD","01177","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665390614","title":"Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs","url":"https://stock-news.laohu8.com/highlight/detail?id=2665390614","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665390614?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:11","pubTimestamp":1788768672,"startTime":"0","endTime":"0","summary":"UPDATE 2-Novartis cholesterol setback tests hopes for emerging heart disease drugsLONDON, Sept 7 (Reuters)-Shares of NovartisNOVN.Sfell more than 3% on Monday after its cholesterol drug failed in a cl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nL1N44Z05O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IHE","TRUH","MHIP","MEDI","VHT","NAMS","LU1571399168.USD","SGXZ99366536.SGD","FHLC","RXL","TBXU","OZEM","MEDX","ELIS","LU0823434583.USD","LU0097036916.USD","LLY","LU1267930730.SGD","ILDR","CANC","AMGN","PBE","BBH","IBBQ","WDNA","IXJ","JDOC","ELIL","BIB","SLN","THNR","PPH","LU2361044865.SGD","HRTS","CURE","FTXH","GDOC","LLYZ","LU2750360641.GBP","PJP","IBB","LU1691799644.USD","XLV","LU2089284900.SGD","LLYX","AGNG","IE00BJJMRY28.SGD","LLII","TMED","IYH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104786890","title":"Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1104786890","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104786890?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:22","pubTimestamp":1788765738,"startTime":"0","endTime":"0","summary":"Swiss pharma giant Novartis AG (NVS.US) has suffered another clinical trial setback, marking the second high-profile candidate to fail in late-stage studies within a single week. The latest casualty...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4599","LU0058720904.USD","BK4581","LU0211331839.USD","LU2089984988.USD","LU0320765992.SGD","TBXU","LU0109394709.USD","LU1023059063.AUD","IE0002141913.USD","IE00BJT1NW94.SGD","BIB","LU2468319806.SGD","BK4585","LU0070302665.USD","LU0320765489.SGD","MEDX","PPH","LU2112291526.USD","LU2242646821.SGD","BK4588","AMGN","LU1057294990.SGD","LU2242652126.USD","BK4007","BK4566","BK4139","LU1571399168.USD","BK4578","IBB","IE00BJJMRZ35.SGD","NVS","LU0868494617.USD","LU0889565916.HKD","IE0009355771.USD","SG9999001440.SGD","PJP","BBH","LU0208291251.USD","IE00B4R5TH58.HKD","BK4533","BK4534","LU1983299246.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU1061106388.HKD","PBE","LU0122379950.USD","LU0289739699.SGD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665365115","title":"A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?","url":"https://stock-news.laohu8.com/highlight/detail?id=2665365115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665365115?lang=en_us&edition=fundamental","pubTime":"2026-09-06 02:01","pubTimestamp":1788631260,"startTime":"0","endTime":"0","summary":"In a consequential week for Novartis, the Swiss drug maker released results for two of three trials that Wall Street has watched for in the second half of the year.Novartis saw U.S.-listed shares soar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1057294990.SGD","PJP","BK4599","LU2242646821.SGD","LU1061106388.HKD","BK4581","LU0889565916.HKD","LU0052756011.USD","BK4139","BK4533","FTXO","LU2125154935.USD","BIB","LU0980610538.SGD","IBBQ","PPH","LU1162221912.USD","IE00BJJMRZ35.SGD","BK4007","LU2112291526.USD","LU2236285917.USD","LU0130102774.USD","TBXU","MEDX","LU0320765489.SGD","IYF","LU0070302665.USD","LU2242652126.USD","TFNS","BK4559","LU0211331839.USD","LU1983299246.USD","LU2456880835.USD","BK4504","LU1074936037.SGD","LU1244550221.USD","LU2360032135.SGD","SG9999001440.SGD","BK4566","BBH","LU0868494617.USD","LU0314106906.USD","NVS","LU0106831901.USD","LU2462157665.USD","LU0128525689.USD","IE00BSNM7G36.USD","PBE","AMGN","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665682593","title":"Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts","url":"https://stock-news.laohu8.com/highlight/detail?id=2665682593","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665682593?lang=en_us&edition=fundamental","pubTime":"2026-09-05 17:01","pubTimestamp":1788598891,"startTime":"0","endTime":"0","summary":"Analysts are intrested in these 5 stocks: ( ($ACRS) ), ( ($EYPT) ), ( ($VRTX) ), ( ($GTLB) ) and ( ($NB) ). Here is a breakdown of their recent","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/weekend-updates/aclaris-eyepoint-vertex-gitlab-niocorp-trending-with-analysts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2417539215.USD","BBH","SG9999001176.SGD","LU0234570918.USD","IE00BZ9MQY76.HKD","IBB","LU2456880835.USD","BK4607","IE0002270589.USD","LU1778281490.HKD","VRTX","BK4613","LU2468319806.SGD","LU1093756325.SGD","LU0417517546.SGD","LU1093756168.USD","SG9999013999.USD","GNMX","IE00B4R5TH58.HKD","LU1069344957.HKD","LU1674673428.USD","TBXU","BK4533","IE00BFTCPJ56.SGD","GTLB","PBE","LU1559883803.SGD","LU2236285917.USD","IBBQ","IE0002141913.USD","IE00B19Z9Z06.USD","LU1035775433.USD","IE00BJJMRZ35.SGD","EYPT","LU0079474960.USD","IDNA","IE0009355771.USD","IE00B2B36J28.USD","IE00B894F039.SGD","LU2462157665.USD","IE00B19Z9P08.USD","LU2362541513.USD","LU2089984988.USD","LU2324357040.USD","BIB","IE00B19Z3B42.SGD","LU0757428866.USD","VERX","LU0289739699.SGD","BK4097"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352504","title":"Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352504","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352504?lang=en_us&edition=fundamental","pubTime":"2026-09-05 06:53","pubTimestamp":1788562416,"startTime":"0","endTime":"0","summary":"Amgen EVP, CFO Thomas J.W. Dittrich files initial beneficial ownership statementAmgen EVP and CFO Thomas J.W. Dittrich reported 16,860 common shares in an initial SEC Form 3 filing.Disclaimer:This new","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6SPhM6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","PJP","LU0289739699.SGD","IBB","LU0058720904.USD","IE0002141913.USD","LU2112291526.USD","BK4599","LU2242646821.SGD","LU2242652126.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU1061106388.HKD","LU0320765992.SGD","BK4566","LU1983299246.USD","BK4533","LU1023059063.AUD","LU1057294990.SGD","IBBQ","BIB","SG9999001440.SGD","AMGN","BK4534","IE0009355771.USD","TBXU","LU0109394709.USD","LU1571399168.USD","PBE","IE00BJT1NW94.SGD","LU2089984988.USD","BK4585","IE00BFTCPJ56.SGD","BK4581","BK4139","IE00B4R5TH58.HKD","LU2468319806.SGD","LU0122379950.USD","BK4588","LU0868494617.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665235617","title":"Amgen is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2665235617","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665235617?lang=en_us&edition=fundamental","pubTime":"2026-09-05 02:47","pubTimestamp":1788547620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMGN/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTXO","LU1074936037.SGD","BBH","BK4582","LU0310799852.SGD","TBXU","LU2361044865.SGD","LU0417517546.SGD","LU1035773651.USD","LU1894683348.USD","LU1814569148.SGD","AMGN","LU0787776722.HKD","LU0942090050.USD","IBB","TFNS","LU0889565916.HKD","IE0002270589.USD","PBE","BK4581","BK4588","IYF","LU0128525929.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0154236417.USD","LU0175139822.USD","LU0868494617.USD","LU1069347547.HKD","BK4533","BK4559","IBBQ","LU0106831901.USD","LU1571399168.USD","LU0130102774.USD","IE00BJT1NW94.SGD","PJP","LU1061106388.HKD","LU0640476718.USD","LU0742534661.SGD","BIB","BK4534","KBWB","PGF","LU0162691827.USD","LU0708994859.HKD","LU0971096721.USD","IE00B4R5TH58.HKD","LU2361044949.HKD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664980438","title":"Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2664980438","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664980438?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:47","pubTimestamp":1788468476,"startTime":"0","endTime":"0","summary":"Regeneron director Kathryn Guarini disposes of 400 common shares worth $340,000Regeneron director Kathryn Guarini sold 400 shares on Sep. 2 at USD 850 per share.She exercised stock options for 400 sha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9s8sKq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Regeneron Director Kathryn Guarini Disposes of 400 Common Shares Worth $340,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0289739699.SGD","LU0109394709.USD","LU0114720955.EUR","IBBQ","BK4139","LU2362540622.SGD","LU1917777945.USD","BK4588","LU0823434583.USD","LU2023250504.SGD","LU0053666078.USD","LU2362541513.USD","LU2362541273.HKD","BK4585","LU2237438978.USD","TBXU","LU1974910355.USD","BBH","LU2468319806.SGD","LU0058720904.USD","LU0889565916.HKD","REGN","LU2106854487.HKD","LU0320765992.SGD","LU0823434740.USD","IBB","LU0882574055.USD","LU2089984988.USD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664012018","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains","url":"https://stock-news.laohu8.com/highlight/detail?id=2664012018","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664012018?lang=en_us&edition=fundamental","pubTime":"2026-09-04 04:35","pubTimestamp":1788467700,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To Competitors Despite Daily GainsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  advanced 1.08% to $151.22 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index  rising 1.06% to 7,747.71 and the Dow Jones Industrial Average  rising 1.18% to 53,686.11.Gilead Sciences Inc. closed 3.86% short of its 52-week high of $157.29, which the company reached on February 11th.The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as Johnson & Johnson  rose 1.17% to $278.43, Pfizer Inc.  fell 0.72% to $28.81, and Abbott Laboratories  fell 1.52% to $108.79.Trading volume  remained 2.3 million below its 50-day average volume of 6.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 3, 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","LU1839511570.USD","LU1674673428.USD","LU0058720904.USD","LU1934455277.USD","TBXU","BK4585","LU0109394709.USD","LU0320765992.SGD","BK4583","IE00B19Z3581.USD","LU0289739699.SGD","LU0823416689.USD","BBH","IE00B19Z3B42.SGD","LU1037948541.HKD","IE00BSNM7G36.USD","LU1066051498.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU1674673691.USD","LU1934455863.HKD","LU2324357040.USD","LU0859254822.USD","BK4532","LU0114720955.EUR","SG9999015945.SGD","LU2357627491.SGD","LU2468319806.SGD","IE00B3T34201.USD","BK4566","LU1778281490.HKD","IBBQ","LU1571399168.USD","TMED","SG9999015952.SGD","IBB","BIB","LU0122379950.USD","LU0965508806.USD","IE00BKVL7J92.USD","BMED","LU1023059063.AUD","LU0234570918.USD","BK4578","LU0882574055.USD","LU1934455194.USD","LU1061106388.HKD","LU1585245621.USD","LU0861579265.USD","MEDI","LU2089984988.USD","GILD","IE0002270589.USD","LU0965509283.SGD","LU0889565916.HKD","SG9999015978.USD","BK4550","LU1430594728.SGD","LU1037948897.HKD","LU2112291526.USD","LU1057294990.SGD","BK4139","BK4588","LU0965509101.SGD","LU1066053197.SGD","IE00B7SZLL34.SGD","BK4568","SG9999015986.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664805389","title":"Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst","url":"https://stock-news.laohu8.com/highlight/detail?id=2664805389","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664805389?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:30","pubTimestamp":1788453034,"startTime":"0","endTime":"0","summary":"Gilead Sciences ($GILD) announced an update on their ongoing clinical study. Gilead Partner Study Marks Milestone in First-Line Stomach Cancer Ther...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gileads-arcus-backed-cancer-trial-reaches-completion-setting-up-a-key-immuno-oncology-catalyst?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gileads-arcus-backed-cancer-trial-reaches-completion-setting-up-a-key-immuno-oncology-catalyst?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4532","LU1430594728.SGD","LU1934455194.USD","GILD","LU0861579265.USD","LU0965509101.SGD","LU1934455277.USD","LU1674673428.USD","LU1571399168.USD","LU2324357040.USD","MEDI","IBB","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU2089984988.USD","LU1778281490.HKD","IBBQ","IE00B3T34201.USD","LU0823416689.USD","LU0882574055.USD","LU1066053197.SGD","TMED","LU0289739699.SGD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU1585245621.USD","BMED","IE00BKVL7J92.USD","LU1061106388.HKD","LU0965508806.USD","BK4566","LU0058720904.USD","BK4588","TBXU","LU0965509283.SGD","BBH","LU0122379950.USD","LU2112291526.USD","LU2468319806.SGD","SG9999015952.SGD","SG9999015945.SGD","SG9999015978.USD","BK4139","LU1839511570.USD","LU1023059063.AUD","BIB","LU1057294990.SGD","LU1066051498.USD","BK4583","LU1037948541.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803700","title":"Vortex Energy to Launch Ground Gravity Survey at Robinsons River Salt Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803700?lang=en_us&edition=fundamental","pubTime":"2026-09-04 00:04","pubTimestamp":1788451496,"startTime":"0","endTime":"0","summary":"Vortex Energy Corp. ( ($TSE:VRTX) ) has issued an update. Vortex Energy Corp. plans to launch a targeted ground gravity survey at its wholly owned ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-to-launch-ground-gravity-survey-at-robinsons-river-salt-project?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0289739699.SGD","LU1674673691.USD","LU0823416689.USD","BK4532","IBB","LU0417517546.SGD","LU1069344957.HKD","BBH","LU0234570918.USD","PBE","IE00B19Z9Z06.USD","IBBQ","BIB","LU0109394709.USD","LU2362541273.HKD","LU0058720904.USD","IE00B2B36J28.USD","LU2362541513.USD","BK4139","IDNA","TBXU","IE00BFTCPJ56.SGD","LU2237438978.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU2362540622.SGD","VRTX","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","IE00BZ9MQY76.HKD","LU0889565916.HKD","SG9999013999.USD","LU1093756168.USD","LU0320765992.SGD","IE0002270589.USD","IE00B19Z3B42.SGD","LU0079474960.USD","LU1430594728.SGD","BK4585","LU2324357040.USD","SGXZ57979304.SGD","IE00B19Z9P08.USD","IE0002141913.USD","GNMX","LU0061475181.USD","LU1035775433.USD","IE00B19Z3581.USD","LU2236285917.USD","SG9999001176.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664704888","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664704888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664704888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:10","pubTimestamp":1788444623,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Teva Pharmaceutical ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XLV","TEVA","LU2324357040.USD","LU1983299246.USD","IE0009355771.USD","LU0320765992.SGD","PTH","BK4584","BK4557","XBI","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4007","BK4559","LU0128526141.USD","BK4566","IE00BJJMRZ35.SGD","BK4596","IDNA","BK4588","IE0002141913.USD","LU0889565916.HKD","BBH","IE00BJT1NW94.SGD","BK4137","BK4581","HCSG","BK4139","BK4585","LABU","RVMD","CANC","IE0009354923.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664741898","title":"Political and General News Events from September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2664741898","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664741898?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:26","pubTimestamp":1788438361,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from September 3Sept 3 (Reuters)-For other diaries, please see:Political and General NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nL4N44V0YD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983299246.USD","LU0320765992.SGD","IE00B4R5TH58.HKD","LU2242652126.USD","AMGN","LU2468319806.SGD","SG9999001440.SGD","LU1057294990.SGD","LU2089984988.USD","BK4566","LU0889565916.HKD","PJP","IBB","BBH","IE00BFTCPJ56.SGD","LU0289739699.SGD","LU1023059063.AUD","IBBQ","LU1061106388.HKD","LU0058720904.USD","LU2242646821.SGD","LU0868494617.USD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00B2B36J28.USD","PBE","IE00BJT1NW94.SGD","LU2112291526.USD","LU0109394709.USD","TBXU","BK4139","IE0009355771.USD","BK4588","BK4599","BIB","BK4533","BK4581","LU1571399168.USD","BK4534","LU0122379950.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664487978","title":"Eikon Therapeutics Names Ching-Pin Chang as Chief Scientific Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2664487978","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664487978?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:32","pubTimestamp":1788435147,"startTime":"0","endTime":"0","summary":"Eikon Therapeutics names Ching-Pin Chang as chief scientific officerEikon Therapeutics named Ching-Pin “CP” Chang executive vice president, chief scientific officer.Chang joins from Bristol Myers Squi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL9l9Cns:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509010.AUD","TMED","IHE","GILD","IE00BQXX3D17.EUR","LU0114720955.EUR","IE00BQXX3C00.GBP","LU2242646821.SGD","TBXU","LU2125154778.USD","LU1934455194.USD","LU1093756168.USD","IE00B64PRP62.GBP","LU1585245621.USD","BK4585","IBBQ","MEDI","LU1236620834.HKD","LU0267386448.USD","LU2133065610.SGD","IBB","LU2095319765.USD","LU1057294990.SGD","NDAQ","BMY","SG9999014021.USD","BK4550","IE00BKPKM429.USD","LU2087621335.USD","LU2089984988.USD","LU0306807586.USD","LU0859254822.USD","IE00BN0W2V16.EUR","LU0109394709.USD","LU0321505868.SGD","BBH","LU2242652126.USD","EIKN","LU1093756325.SGD","FTXH","BCDF","LU1291159041.SGD","LU2360032135.SGD","LU1023059063.AUD","LU1718418525.SGD","LU1983299246.USD","LU0122379950.USD","LU1839511570.USD","BIB","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664482770","title":"Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664482770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664482770?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 6.3% to 5.59 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.Sino Biopharmaceutical Ltd. closed 39% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 4.8% and Amgen Inc. remained unchanged.Trading volume totaled 127.7 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","LU0289739699.SGD","BK1589","BK1191","BIB","LU0889565916.HKD","LU1983299246.USD","LU2089984988.USD","LU1023059063.AUD","BK1521","AMGN","LU2242646821.SGD","BK4139","IE00BZ08YR35.GBP","IE0009355771.USD","IE00B2B36J28.USD","IE00BZ08YS42.EUR","HK0000165453.HKD","IBBQ","IE00BJJMRZ35.SGD","BK4599","LU2468319806.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4533","LU1057294990.SGD","PBE","BK4534","PJP","BK4585","IE0002141913.USD","BK1515","IE00BJT1NW94.SGD","BBH","LU1571399168.USD","LU2112291526.USD","LU0320765992.SGD","IBB","LU2242652126.USD","BK4566","LU0122379950.USD","TBXU","IE00BFTCPJ56.SGD","BK4581","BK4588","IE00BZ08YT58.USD","LU0868494617.USD","LU0058720904.USD","SG9999001440.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664828323","title":"Buy Rating Reiterated on Daraxonrasib Strength, RASolve 301 Upsizing, and Unchanged $315 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2664828323","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664828323?lang=en_us&edition=fundamental","pubTime":"2026-09-03 09:25","pubTimestamp":1788398717,"startTime":"0","endTime":"0","summary":"LifeSci Capital analyst Charles Zhu maintained a Buy rating on Revolution Medicines yesterday and set a price target of $315.00. Charles Zhu has gi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-daraxonrasib-strength-rasolve-301-upsizing-and-unchanged-315-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/buy-rating-reiterated-on-daraxonrasib-strength-rasolve-301-upsizing-and-unchanged-315-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IDNA","IE00BJT1NW94.SGD","LU0109394709.USD","BBH","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","RVMD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","CANC","IE0009354923.USD","LU0889565916.HKD","PTH","IE0002141913.USD","BK4139","IE0009355771.USD","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664422868","title":"Vertex Minerals Seeks Trading Halt Ahead of Capital Raising Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2664422868","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664422868?lang=en_us&edition=fundamental","pubTime":"2026-09-03 07:44","pubTimestamp":1788392661,"startTime":"0","endTime":"0","summary":"Vertex Minerals Ltd. ( ($AU:VTX) ) has shared an update. Vertex Minerals Ltd, an Australian minerals and resources company listed on the ASX as VTX...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-seeks-trading-halt-ahead-of-capital-raising-plan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-minerals-seeks-trading-halt-ahead-of-capital-raising-plan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","IE00B19Z9Z06.USD","LU1430594728.SGD","MTX","IE0002141913.USD","LU0289739699.SGD","LU0757428866.USD","LU0079474960.USD","BBH","LU0823416689.USD","LU2236285917.USD","LU0061475181.USD","IBBQ","LU0889565916.HKD","LU2362540622.SGD","TBXU","LU2362541273.HKD","LU1674673691.USD","LU2362541513.USD","LU2324357040.USD","SG9999001176.SGD","LU0256863811.USD","LU2237438978.USD","IE00BFTCPJ56.SGD","PBE","IE00B19Z3B42.SGD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4532","BK4585","IE00B19Z9P08.USD","IE00BZ9MQY76.HKD","SG9999001176.USD","LU2456880835.USD","SGXZ57979304.SGD","LU0109394709.USD","LU1559883803.SGD","GNMX","BK4023","LU0320765992.SGD","VRTX","IE0009355771.USD","BIB","LU0058720904.USD","LU2417539215.USD","LU1585245621.USD","IDNA","LU0432979614.USD","SG9999013999.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664844659","title":"NEJM publishes Phase 1/2 clinical data on daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2664844659","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664844659?lang=en_us&edition=fundamental","pubTime":"2026-09-03 05:55","pubTimestamp":1788386116,"startTime":"0","endTime":"0","summary":"Revolution Medicines (RVMD) “announced that The New England Journal of Medicine has published a report describing data from the Phase 1/2 clinical ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nejm-publishes-phase-1-2-clinical-data-on-daraxonrasib-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nejm-publishes-phase-1-2-clinical-data-on-daraxonrasib-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFTCPJ56.SGD","BK4139","CANC","IE0002141913.USD","IE00BJJMRZ35.SGD","IDNA","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","RVMD","PTH","LU0320765992.SGD","LU0889565916.HKD","IE0009355771.USD","IE00B2B36J28.USD","BBH","IE0009354923.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}